Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ)

Primary Care Respiratory Journal

Volumn 18, Issue 3, 2009, Pages 198-207

  Bailey, William C ^a   Sciurba, Frank C ^b   Hanania, Nicola A ^c   Donohue, James F ^d   Ferguson, Gary T ^e   Zibrak, Joseph D ^f   Sharafkhaneh, Amir ^c,g   Marcus, Philip ^h,i   Rosa, Kathleen ^j   Piault, Elisabeth C ^j   Martinez, Fernando J ^k  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e Pulmonary Research Institute of Southeast Michigan   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h ST FRANCIS HOSPITAL   (United States)

ⁱ NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^j MAPI VALUES   (United States)

^k UNIVERSITY OF MICHIGAN   (United States)

more..

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease (COPD); Patient reported questionnaire; Predictive validity; Symptom

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MEDICAL EXPERT; PARAMETER; PHYSICIAN; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SAMPLE; SCORING SYSTEM; SPIROMETRY; VALIDATION STUDY;

AGED; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 69749121177     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2009.00032     Document Type: Article

References (33)

1. World Health Organisation, Colin D.Mathers, Claudia Stein, Doris Ma Fat, Chalapati Rao, Mie Inoue, et al. Global Burden of Disease 2000: Version 2 methods and results:1-108.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2007:1-30.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349(9064):1498- 504. http://dx.doi.org/10.1016/S0140-6736(96)07492-7502
4. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003;290(17):2301-2312 http://dx.doi.org/10.1001/jama.290.17.2301 (Pubitemid 37430563)
5. American Association for Respiratory Care. Confronting COPD in America: Executive Summary. http://www aarc org/resources/confronting-copd/exesum pdf (last accessed 19 September 2008).
6. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(5 Pt 1):1418-1422 (Pubitemid 28242071)
7. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169(12):1298-1303 http://dx.doi.org/10. 1164/rccm.200310-1443OC (Pubitemid 39571857)
8. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic Obstructive Pulmonary Disease Surveillance - United States, 1971-2000. In: Surveillance Summaries, August 2, 2002. MMWR 2002;51(No.):1-16.
9. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946 http://dx.doi.org/10.1183/09031936.04.00014304 (Pubitemid 38807371)
10. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(5 Suppl 2):398S-401S. http://dx.doi.org/10.1378/ chest.117.5-suppl-2.398S (Pubitemid 30314474)
11. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012 http://dx.doi.org/10. 1056/ NEJMoa021322 (Pubitemid 38269277)
12. Celli BR, Calverley PM, Rennard SI, et al. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med 2005;99(12):1546-1554 http://dx.doi.org/10.1016/j.rmed.2005.03.019 (Pubitemid 41683935)
13. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56(11):880-887 http://dx.doi.org/10.1136/ thorax.56.11.880 (Pubitemid 32999838)
14. Selim AJ, Ren XS, Fincke G, Rogers W, Lee A, Kazis L. A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest 1997;111(6):1607-1614 http://dx.doi.org/10.1378/ chest.111.6.1607 (Pubitemid 27260092)
15. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85 Suppl B:25-31.
16. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85(6):751-758 http://dx.doi.org/ 10.1378/chest.85.6.751
17. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113(1):59-65. http://dx.doi.org/10.1016/j.jaci.2003.09.008 (Pubitemid 38096162)
18. Tu SP, McDonell MB, Spertus JA, Steele BG, Fihn SD. A new self-administered questionnaire to monitor health-related quality of life in patients with COPD. Ambulatory Care Quality Improvement Project (ACQUIP) Investigators. Chest 1997;112(3):614-622 http://dx.doi.org/10.1378/chest.112.3. 614
19. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13. http://dx.doi.org/10.1186/ 1477-7525-1-13
20. Wijkstra PJ, TenVergert EM, Van Altena R, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994;49(5):465-467 http://dx.doi.org10.1136/thx.49.5.465 (Pubitemid 24170398)
21. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998;92(10):1207-14. http://dx.doi.org/10.1016/S0954-6111(98)90423-90431
22. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007).
23. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3(3):234-238 http://dx.doi.org/10. 1513/pats.200509-103SF (Pubitemid 43668187)
24. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2006;12(2):113-117 http://dx.doi.org/10.1097/01.mcp.0000208450.50231.c6 (Pubitemid 44384785)
25. Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J 2005;26(2):242-248 http://dx.doi.org/10.1183/09031936.05.00010604
26. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006;100(10):1767-74.http://dx.doi.org/10.1016/j.rmed.2006.01.026 (Pubitemid 44283757)
27. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008;31(1):204-212 http://dx.doi.org/10.1183/ 09031936.00114307
28. Girault C, Muir JF, Mihaltan F, et al. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD. Chest 1996;110(5):1203-1211 http://dx.doi.org/10.1378/chest.110.5.1203 (Pubitemid 26380474)
29. van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006;129(3):509-517 http://dx.doi.org/ 10.1378/chest.129.3.509
30. Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361(9356):449-56. http://dx.doi.org/10. 1016/ S0140-6736(03)12459-12462 (Pubitemid 36173708)
31. Mahler DA, Wire P, Horstman D, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166(8):1084-1091 http://dx.doi.org/10.1164/rccm.2112055 (Pubitemid 35178706)
32. European Agency for the Evaluation of Medicinal Products. Human Medicines Evaluation Unit. CPMP/ICH/363/96. ICH Topic E9. Statistical Principles for Clinical Trials. Step 4, Consensus guideline, 1998.
33. European Agency for the Evaluation of Medicinal Products. Human Medicines Evaluation Unit. CPMP/ICH/364/96. ICH Topic E 10. Choice of Control Group in Clinical Trials. Step 4, Consensus guideline, 2000.